GE Healthcare taps new president, Hogan departs for energy industry

TriMed Staff | | Health Imaging | Artificial Intelligence
GE Chairman and CEO Jeff Immelt has appointed John Dineen as president and CEO of GE Healthcare.

Joseph Hogan, the former CEO and president of GE Healthcare, has accepted a position as CEO of ABB, a producer of power and automation systems. Hogan, who had a 23-year career at GE, will begin with ABB on September 1.

Dineen is a 22-year GE veteran and has been president and CEO of GE Transportation since 2005, according to the company. In his new position, Dineen will be located at GE Healthcare’s London headquarters.

Lorenzo Simonelli will succeed Dineen as president and CEO of GE Transportation, according to Immelt.

Before heading GE Transportation, Dineen served as vice president and general manager of Plastics at GE Advanced Materials and held various assignments in corporate finance, the company said. Dineen also served as general manager of GE Power Equipment; general manager of the Meter business; general manager of the Microwave and Air-conditioning businesses; manager of finance for GE Asia in Hong Kong; and president of GE Plastics-Pacific.

TriMed Staff

Related Content

AI beats standard regression models at predicting lung cancer risk
AI reduces CT lung cancer screening workload by nearly 80%
How AI and CCTA help heart teams plan ahead before PCI
5 steps for evaluating radiology AI applications
Adaptable AI system detects subtle changes in imaging, has potential across multiple clinical settings
New algorithm models radiologists' eye movements to interpret chest X-rays

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.